Chemotherapy-induced neutropenia as a prognostic factor in advanced non-small-cell lung cancer: results from Japan Multinational Trial Organization LC00-03

American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003

Pfister, D. G., Johnson, D. H., Azzoli, C. G., Sause, W. T., Smith, T. J., Baker, S., Olak, J., Stover, D. E., Strawn, J. R., Turrisi, A. T., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2004.09.053 · Cited by 1,411 · see citing works

Conventional-Dose Chemotherapy Compared with High-Dose Chemotherapy plus Autologous Hematopoietic Stem-Cell Transplantation for Metastatic Breast Cancer

Stadtmauer, E. A., O’Neill, A., Goldstein, L. J., Crilley, P. A., Mangan, K. F., Ingle, J. N., Brodsky, I., Martino, S., Lazarus, H. M., Erban, J. K., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200004133421501 · Cited by 459 · see citing works

Prognostic factors for survival in advanced non-small-cell lung cancer: univariate and multivariate analyses including recursive partitioning and amalgamation algorithms in 1,052 patients. The European Lung Cancer Working Party.

Paesmans, M., Sculier, J., Libert, P., Bureau, G., Dabouis, G., Thiriaux, J., Michel, J., Cutsem, O. V., SERGYSELS, R., & Mommen, P. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.5.1221 · Cited by 386 · see citing works

Irinotecan Therapy in Adults With Recurrent or Progressive Malignant Glioma

Friedman, H. S., Petros, W. P., Friedman, A. H., Schaaf, L. J., Kerby, T., Lawyer, J., Parry, M., Houghton, P. J., Lovell, S., Rasheed, K., et al. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.5.1516 · Cited by 355 · see citing works

Pretreatment neutrophil count as an independent prognostic factor in advanced non-small-cell lung cancer: an analysis of Japan Multinational Trial Organisation LC00–03

Teramukai, S., Kitano, T., Kishida, Y., Kawahara, M., Kubota, K., Komuta, K., Minato, K., Mio, T., Fujita, Y., Yonei, T., et al. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2009.01.023 · Cited by 282 · see citing works

How to calculate the dose of chemotherapy

Gurney, H. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600139 · Cited by 252 · see citing works

Chemotherapy-induced neutropenia and treatment efficacy in advanced non-small-cell lung cancer: a pooled analysis of three randomised trials

Maïo, M. D., Gridelli, C., Gallo, C., Shepherd, F. A., Piantedosi, F. V., Cigolari, S., Manzione, L., Illiano, A., Barbera, S., Robbiati, S. F., et al. (2005) · The Lancet Oncology · doi:10.1016/s1470-2045(05)70255-2 · Cited by 235 · see citing works

Disease Control Rate at 8 Weeks Predicts Clinical Benefit in Advanced Non–Small-Cell Lung Cancer: Results From Southwest Oncology Group Randomized Trials

Lara, P. N., Redman, M. W., Kelly, K. L., Edelman, M. J., Williamson, S. K., Crowley, J. J., & Gandara, D. R. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.0344 · Cited by 182 · see citing works

Adverse effect of anticonvulsants on efficacy of chemotherapy for acute lymphoblastic leukaemia

Relling, M. V., Pui, C., Sandlund, J. T., Rivera, G. K., Hancock, M. L., Boyett, J. M., Schuetz, E. G., & Evans, W. E. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02503-4 · Cited by 182 · see citing works

Haematological toxicity: a marker of adjuvant chemotherapy efficacy in stage II and III breast cancer

Saarto, T., BLOMQVIST, C. P., Rissanen, P., Auvinen, A. P., & Elomaa, I. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.49 · Cited by 128 · see citing works

Moderate neutropenia with adjuvant CMF confers improved survival in early breast cancer

Cameron, D., Massie, C. E., Kerr, G. R., & Leonard, R. C. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601366 · Cited by 117 · see citing works

Leucocyte nadir as a marker for chemotherapy efficacy in node-positive breast cancer treated with adjuvant CMF

Poikonen‐Saksela, P., Saarto, T., Lundin, J. E., Joensuu, H., & BLOMQVIST, C. P. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690594 · Cited by 113 · see citing works

A prognostic model for advanced stage nonsmall cell lung cancer

Mandrekar, S. J., Schild, S. E., Hillman, S. L., Allen, K. L., Marks, R. S., Mailliard, J. A., Krook, J. E., Maksymiuk, A. W., Chansky, K., Kelly, K. L., et al. (2006) · Cancer · doi:10.1002/cncr.22049 · Cited by 103 · see citing works

Predictive value of chemotherapy-induced neutropenia for the efficacy of oral fluoropyrimidine S-1 in advanced gastric carcinoma

Yamanaka, T., Matsumoto, S., Teramukai, S., Ishiwata, R., Nagai, Y., & Fukushima, M. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603831 · Cited by 86 · see citing works

Phase III Trial of High-Dose Sequential Chemotherapy With Peripheral Blood Stem Cell Support Compared With Standard Dose Chemotherapy for First-Line Treatment of Advanced Ovarian Cancer: Intergroup Trial of the AGO-Ovar/AIO and EBMT

Möbus, V. J., Wandt, H., Frickhofen, N., Bengala, C., Champion, K. M., Kimmig, R., Ostermann, H., Hinke, A., & Ledermann, J. A. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.7527 · Cited by 78 · see citing works

Vinorelbine plus gemcitabine followed by docetaxel versus carboplatin plus paclitaxel in patients with advanced non-small-cell lung cancer: a randomised, open-label, phase III study

Kubota, K., Kawahara, M., Ogawara, M., Nishiwaki, Y., Komuta, K., Minato, K., Fujita, Y., Teramukai, S., Fukushima, M., & Furuse, K. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70261-4 · Cited by 75 · see citing works

Chemotherapy-induced neutropenia as a prognostic factor in patients with advanced non-small cell lung cancer treated with front-line docetaxel–gemcitabine chemotherapy

Pallis, A. G., Agelaki, S., Kakolyris, S., Kotsakis, A. P., Kalykaki, A., Vardakis, N., Papakotoulas, P., Agelidou, A., Geroyianni, A., Agelidou, M., et al. (2008) · Lung Cancer · doi:10.1016/j.lungcan.2008.03.030 · Cited by 48 · see citing works

Dose intensity correlate with survival in elderly patients treated with chemotherapy for advanced non-small cell lung cancer

Luciani, A., Bertuzzi, C., Ascione, G., Gennaro, E. D., Bozzoni, S., Zonato, S., Ferrari, D., & Foa, P. (2009) · Lung Cancer · doi:10.1016/j.lungcan.2008.12.019 · Cited by 41 · see citing works

Tumor-related leucocytosis and chemotherapy-induced neutropenia: Linked or independent prognostic factors for advanced non-small cell lung cancer?

Maione, P., Rossi, A., Maïo, M. D., & Gridelli, C. (2009) · Lung Cancer · doi:10.1016/j.lungcan.2009.02.022 · Cited by 31 · see citing works

Correlation between tumor response to first-line chemotherapy and prognosis in advanced gastric cancer patients

Ichikawa, W., & Sasaki, Y. (2006) · Annals of Oncology · doi:10.1093/annonc/mdl174 · Cited by 30 · see citing works

Getting the right dose in cancer chemotherapy – time to stop using surface area?

Newell, D. R. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600226 · Cited by 27 · see citing works

Usefulness of the Neutrophil-to-Lymphocyte Ratio in Predicting Short- and Long-Term Mortality in Breast Cancer Patients

Azab, B., Bhatt, V. R., Phookan, J., Murukutla, S., Kohn, N., Terjanian, T., & Widmann, W. D. (2012) · Annals of Surgical Oncology · doi:10.1245/s10434-011-1814-0 · Cited by 447 · see citing works

High preoperative neutrophil-lymphocyte ratio predicts poor survival in patients with gastric cancer

Shimada, H., Takiguchi, N., Kainuma, O., Soda, H., Ikeda, A., Cho, A., Miyazaki, A., Gunji, H., Yamamoto, H., & Nagata, M. (2010) · Gastric Cancer · doi:10.1007/s10120-010-0554-3 · Cited by 383 · see citing works

The prognostic value of preoperative NLR, d-NLR, PLR and LMR for predicting clinical outcome in surgical colorectal cancer patients

Ying, H.-Q., Deng, Q.-W., He, B., Pan, Y.-Q., Wang, F., Sun, H.-L., Chen, J., Liu, X., & Wang, S.-K. (2014) · Medical Oncology · doi:10.1007/s12032-014-0305-0 · Cited by 319 · see citing works

Impact of chemotherapy-induced neutropenia (CIN) and febrile neutropenia (FN) on cancer treatment outcomes: An overview about well-established and recently emerging clinical data

Lalami, Y., & Klastersky, J. A. (2017) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2017.11.005 · Cited by 137 · see citing works

The effect of peripheral blood values on prognosis of patients with locally advanced gastric cancer before treatment

Aliustaoğlu, M., Bilici, A. E., Ustaalıoğlu, B. B. Ö., Konya, V., Gücün, M., Şeker, M., & Gümüş, M. (2009) · Medical Oncology · doi:10.1007/s12032-009-9335-4 · Cited by 128 · see citing works

High neutrophil-to-lymphocyte ratio is an independent marker of poor disease-specific survival in patients with oral cancer

Perisanidis, C., Kornek, G. V., Poeschl, P. W., Holzinger, D., Pirklbauer, K., Schopper, C., & Ewers, R. (2013) · Medical Oncology · doi:10.1007/s12032-012-0334-5 · Cited by 111 · see citing works

Preoperative neutrophil/lymphocyte ratio and prognostic nutritional index predict survival in patients with non-small cell lung cancer

Shimizu, K., Okita, R., Saisho, S., Maeda, A., Nojima, Y., & Nakata, M. (2015) · World Journal of Surgical Oncology · doi:10.1186/s12957-015-0710-7 · Cited by 102 · see citing works

A novel tumor-immune microenvironment (TIME)-on-Chip mimics three dimensional neutrophil-tumor dynamics and neutrophil extracellular traps (NETs)-mediated collective tumor invasion

Surendran, V., Rutledge, D., Colmon, R., & Chandrasekaran, A. (2021) · Biofabrication · doi:10.1088/1758-5090/abe1cf · Cited by 99 · see citing works

Current management of chemotherapy-induced neutropenia in adults: key points and new challenges

Ba, Y., Shi, Y., Jiang, W., Feng, J., Cheng, Y., Xiao, L., Zhang, Q., Qiu, W., Xu, B., Xu, R., et al. (2020) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2020.0069 · Cited by 97 · see citing works

Early neutrophil-to-lymphocyte ratio reduction as a surrogate marker of prognosis in never smokers with advanced lung adenocarcinoma receiving gefitinib or standard chemotherapy as first-line therapy

Lee, Y., Kim, S. H., Han, J., Kim, H. T., Yun, T., & Lee, J. S. (2012) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-012-1281-4 · Cited by 89 · see citing works

Meta-analysis of neutropenia or leukopenia as a prognostic factor in patients with malignant disease undergoing chemotherapy

Shitara, K., Matsuo, K., Oze, I., Mizota, A., Kondo, C., Nomura, M., Yokota, T., Takahari, D., Ura, T., & Muro, K. (2010) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-010-1487-6 · Cited by 87 · see citing works

Prognostic significance of the ratio of absolute neutrophil to lymphocyte counts for breast cancer patients with ER/PR-positivity and HER2-negativity in neoadjuvant setting

Koh, Y. W., Lee, H. J., Ahn, J., Lee, J. W., & Gong, G. (2014) · Tumor Biology · doi:10.1007/s13277-014-2282-5 · Cited by 67 · see citing works

Preoperative platelet-lymphocyte ratio is superior to neutrophil-lymphocyte ratio as a prognostic factor for soft-tissue sarcoma

Que, Y., Qiu, H., Li, Y., Chen, Y., Xiao, W., Zhou, Z., & Zhang, X. (2015) · BMC Cancer · doi:10.1186/s12885-015-1654-6 · Cited by 67 · see citing works

Neutropenia as a prognostic factor in advanced gastric cancer patients undergoing second-line chemotherapy with weekly paclitaxel

Shitara, K., Matsuo, K., Takahari, D., Yokota, T., Shibata, T., Ura, T., Ito, S., Sawaki, A., Tajika, M., Kawai, H., et al. (2010) · Annals of Oncology · doi:10.1093/annonc/mdq248 · Cited by 67 · see citing works

Ethnic Difference in Hematological Toxicity in Patients with Non-small Cell Lung Cancer Treated with Chemotherapy: A Pooled Analysis on Asian versus Non-Asian in Phase II and III Clinical Trials

Hasegawa, Y., Kawaguchi, T., Kubo, A., Ando, M., Shiraishi, J., Isa, S., Tsuji, T., Tsujino, K., Ou, S. I., Nakagawa, K., et al. (2011) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31822722b6 · Cited by 65 · see citing works

Neutrophil count is associated with survival in localized prostate cancer

Bahig, H., Taussky, D., Delouya, G., Nadiri, A., Gagnon-Jacques, A., Bodson‐Clermont, P., & Soulières, D. (2015) · BMC Cancer · doi:10.1186/s12885-015-1599-9 · Cited by 65 · see citing works

Neutrophil/Lymphocyte ratio has no predictive or prognostic value in breast cancer patients undergoing preoperative systemic therapy

Suppan, C., Bjelic‐Radisic, V., Garde, M. L., Groselj‐Strele, A., Eberhard, K., Samonigg, H., Loibner, H., Dandachi, N., & Balić, M. (2015) · BMC Cancer · doi:10.1186/s12885-015-2005-3 · Cited by 62 · see citing works

Elevated peripheral blood lymphocyte-to-monocyte ratio predicts a favorable prognosis in the patients with metastatic nasopharyngeal carcinoma

Jiang, R., Cai, X.-Y., Yang, Z.-H., Yan, Y., Zou, X., Guo, L., Sun, R., Luo, D., Chen, Q.-Y., Huang, P., et al. (2015) · 癌症：英文版 · doi:10.1186/s40880-015-0025-7 · Cited by 58 · see citing works

Neutrophil-to-lymphocyte ratio may be associated with the outcome in patients with prostate cancer

Minardi, D., Scartozzi, M., Montesi, L., Santoni, M., Burattini, L., Bianconi, M., Lacetera, V., Milanese, G., Cascinu, S., & Muzzonigro, G. (2015) · SpringerPlus · doi:10.1186/s40064-015-1036-1 · Cited by 53 · see citing works

Prognostic value of preoperative peripheral neutrophil-to-lymphocyte ratio in patients with HBV-associated hepatocellular carcinoma after radical hepatectomy

Fu, S., Shen, S., Li, S., Hua, Y., Hu, W., Liang, L., & Peng, B. (2013) · Medical Oncology · doi:10.1007/s12032-013-0721-6 · Cited by 50 · see citing works

Neutrophil extracellular traps in cancer

Shahzad, M. H., Rayes, R. F., Cools‐Lartigue, J., & Spicer, J. D. (2025) · Nature reviews. Cancer · doi:10.1038/s41568-025-00888-7 · Cited by 52 · see citing works

Prognostic impact of a new score using neutrophil-to-lymphocyte ratios in the serum and malignant pleural effusion in lung cancer patients

Lee, Y. S., Nam, H., Lim, J. H., Kim, J. S., Moon, Y., Cho, J. H., Ryu, J., Kwak, S. M., & Lee, H. L. (2017) · BMC Cancer · doi:10.1186/s12885-017-3550-8 · Cited by 44 · see citing works

Influence of Smoking on the Pharmacokinetics and Toxicity Profiles of Taxane Therapy

de Graan, A. M., Loos, W. J., Friberg, L. E., Baker, S. D., van der Bol, J. M., van Doorn, L., Wiemer, E. A. C., van der Holt, B., Verweij, J., & Mathijssen, R. H. J. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0728 · Cited by 39 · see citing works

An increase in the neutrophil-to-lymphocyte ratio during adjuvant chemotherapy indicates a poor prognosis in patients with stage II or III gastric cancer

Mori, M., Shuto, K., Kosugi, C., Narushima, K., Hayashi, H., Matsubara, H., & Koda, K. (2018) · BMC Cancer · doi:10.1186/s12885-018-5171-2 · Cited by 37 · see citing works

Albumin and Neutrophil Combined Prognostic Grade as a New Prognostic Factor in Non-Small Cell Lung Cancer: Results from a Large Consecutive Cohort

Sun, H., Hu, P., Shen, H., Dong, W., Zhang, T., Liu, Q., & Du, J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0144663 · Cited by 34 · see citing works

Prognostic impact of the prognostic nutritional index in cases of resected oral squamous cell carcinoma: a retrospective study

Abe, A., Hayashi, H., Ishihama, T., & Furuta, H. (2021) · BMC Oral Health · doi:10.1186/s12903-021-01394-6 · Cited by 33 · see citing works

Neutrophil/lymphocyte ratio has a prognostic value for patients with terminal cancer

Nakamura, Y., Watanabe, R., Katagiri, M., Saida, Y., Katada, N., Watanabe, M., Okamoto, Y., Asai, K., Enomoto, T., Kiribayashi, T., et al. (2016) · World Journal of Surgical Oncology · doi:10.1186/s12957-016-0904-7 · Cited by 31 · see citing works

Randomised phase II study comparing dose-escalated weekly paclitaxel vs standard-dose weekly paclitaxel for patients with previously treated advanced gastric cancer

Shitara, K., Yuki, S., Tahahari, D., Nakamura, M., Kondo, C., Tsuda, T., Kii, T., Tsuji, Y., Utsunomiya, S., Ichikawa, D., et al. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.726 · Cited by 30 · see citing works

Patient-tailored modulation of the immune system may revolutionize future lung cancer treatment

Heuvers, M. E., Aerts, J. G. J. V., Cornelissen, R., Groen, H. J. M., Hoogsteden, H. C., & Hegmans, J. P. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-580 · Cited by 28 · see citing works

Impact of baseline and nadir neutrophil index in non-small cell lung cancer and ovarian cancer patients: Assessment of chemotherapy for resolution of unfavourable neutrophilia

Carus, A., Gurney, H., Gebski, V., Harnett, P. R., Hui, R., Kefford, R. F., Wilcken, N. R. C., Ladekarl, M. B., von der Maase, H., & Donskov, F. N. (2013) · Journal of Translational Medicine · doi:10.1186/1479-5876-11-189 · Cited by 28 · see citing works

Modest Reductions in Dose Intensity and Drug-Induced Neutropenia have No Major Impact on Survival of Patients with Non-small Cell Lung Cancer Treated with Platinum-Doublet Chemotherapy

Brunetto, A. T., Carden, C. P., Myerson, J., Faria, A. L., Ashley, S. E., Popat, S., & O'Brien, M. E. R. (2010) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181eba7f9 · Cited by 25 · see citing works

Effect of early use of Chinese herbal products on mortality rate in patients with lung cancer

Shen, H., & Wen, S. (2017) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2017.09.025 · Cited by 24 · see citing works

The association between neutropenia and prognosis in stage III colorectal cancer patients receiving adjuvant chemotherapy

Sunaga, T., Suzuki, S., Kogo, M., Kurihara, T., Kaji, S., Koike, N., Harada, N., Suzuki, M., & Kiuchi, Y. (2013) · European Journal of Cancer Care · doi:10.1111/ecc.12120 · Cited by 24 · see citing works

Platelet Distribution Width as a Predictor of Metastasis in Gastric Cancer Patients

Günaldı, M., Erdem, D., Göksu, S. S., Gündüz, Ş., Okuturlar, Y., Tiken, E. E., Aksoy, H., & Yıldırım, M. (2016) · Journal of Gastrointestinal Cancer · doi:10.1007/s12029-016-9886-5 · Cited by 23 · see citing works

Chemotherapy-induced neutropenia and treatment efficacy in advanced non-small-cell lung cancer: a pooled analysis of 6 randomized trials

Gargiulo, P., Arenare, L., Gridelli, C., Morabito, A., Ciardiello, F., Gebbia, V., Maione, P., Spagnuolo, A., Palumbo, G., Esposito, G., et al. (2021) · BMC Cancer · doi:10.1186/s12885-021-08323-4 · Cited by 22 · see citing works

Prognostic value of chemotherapy-induced neutropenia at the first cycle in invasive breast cancer

Ma, R.-M., Chen, C.-Z., Zhang, W., You, J., Huang, D.-P., & Guo, G.-L. (2016) · Medicine · doi:10.1097/md.0000000000003240 · Cited by 23 · see citing works

Optimized Dosing: The Next Step in Precision Medicine in Non-Small-Cell Lung Cancer

Boosman, R. J., Burgers, J. A., Smit, E. F., Steeghs, N., van der Wekken, A. J., Beijnen, J. H., Huitema, A. D. R., & ter Heine, R. (2021) · Drugs · doi:10.1007/s40265-021-01654-3 · Cited by 20 · see citing works

Prognostic potential of pre-partum blood biochemical and immune variables for postpartum mastitis risk in dairy cows

Guan, R., Wang, D., Wang, B., Jiang, L., & Liu, J. (2020) · BMC Veterinary Research · doi:10.1186/s12917-020-02314-6 · Cited by 20 · see citing works

Chemotherapy-induced neutropenia as a prognostic factor in patients with metastatic pancreatic cancer treated with gemcitabine

Otake, A., Tsuji, D., Taku, K., Kawasaki, Y., Yokoi, M., Nakamori, H., Osada, M., Matsumoto, M., Inoue, K., Hirai, K., et al. (2017) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-017-2260-0 · Cited by 19 · see citing works

Usefulness of the neutrophil-to-lymphocyte ratio in predicting lymph node metastasis in patients with non-small cell lung cancer

Huang, C., Yue, J., Li, Z., Li, N., Zhao, J., & Qi, D. (2015) · Tumor Biology · doi:10.1007/s13277-015-3462-7 · Cited by 17 · see citing works

Phase II, Multicenter, Single-arm Trial of Eribulin as First-line Therapy for Patients With Aggressive Taxane-pretreated HER2-Negative Metastatic Breast Cancer: The MERIBEL Study

Ortega, V., Antón, A., Garau, I., Afonso, N., Calvo, L., Fernández, Y., Martinez‐García, M., Blanco, E., Zamora, P. M., García, M., et al. (2018) · Clinical Breast Cancer · doi:10.1016/j.clbc.2018.12.012 · Cited by 17 · see citing works

Can body composition be used to optimize the dose of platinum chemotherapy in lung cancer? A feasibility study

Crosby, V., D’Souza, C., Bristow, C., Proffitt, A., Hussain, A., Potter, V. A., Hennig, I. M., O’Connor, R. A., Baracos, V. E., & Wilcock, A. (2016) · Supportive Care in Cancer · doi:10.1007/s00520-016-3518-2 · Cited by 16 · see citing works

Pretreated baseline neutrophil count and chemotherapy‐induced neutropenia may be conveniently available as prognostic biomarkers in advanced gastric cancer

Chen, Z., Chen, W., Wang, J., Zhu, M., & Zhuang, Z. (2015) · Internal Medicine Journal · doi:10.1111/imj.12786 · Cited by 16 · see citing works

Dose individualisation in oncology using chemotherapy‐induced neutropenia: Example of docetaxel in non‐small cell lung cancer patients

Lombard, A., Mistry, H. B., Aarons, L. J., & Ogungbenro, K. (2020) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.14614 · Cited by 14 · see citing works

Timing of chemotherapy-induced neutropenia is a prognostic factor in patients with metastatic non-small-cell lung cancer: a retrospective analysis in gemcitabine-plus-platinum-treated patients

Jang, S. H., Kim, S. Y., Kim, J., Park, S., Hwang, Y. I., Kim, D.-G., & Jung, K. (2012) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-012-1341-9 · Cited by 15 · see citing works

Myelosuppression induced by concurrent chemoradiotherapy as a prognostic factor for patients with locally advanced non-small cell lung cancer

Hirose, T. (2011) · Oncology Letters · doi:10.3892/ol.2011.348 · Cited by 14 · see citing works

The Association Between Different Patterns of Traditional Chinese Medicine Treatment and All-Cause Mortality Among Cancer Patients

Lu, S., Chen, J.-J., Pan, J., Fu, Z.-X., Wu, J.-L., & Hsieh, T. (2019) · Integrative Cancer Therapies · doi:10.1177/1534735418823273 · Cited by 14 · see citing works

Neutropenia during the First Cycle of Induction Chemotherapy Is Prognostic for Poor Survival in Locoregionally Advanced Nasopharyngeal Carcinoma: A Real-World Study in an Endemic Area

Xu, C., Yang, S.-P., Zhang, Y., Tang, L., Zhou, G., Liu, X., Mao, Y., Guo, R., Li, W., Chen, L., et al. (2017) · Cancer Research and Treatment · doi:10.4143/crt.2017.255 · Cited by 12 · see citing works

Estimated Creatinine Clearance Rate Is Associated With the Treatment Effectiveness and Toxicity of Pemetrexed As Continuation Maintenance Therapy for Advanced Nonsquamous Non–Small-Cell Lung Cancer

Chen, C., Lin, J., Huang, J., Chen, K., Shih, J., Yu, C., & Yang, P. (2015) · Clinical Lung Cancer · doi:10.1016/j.cllc.2015.01.001 · Cited by 11 · see citing works

FDG uptake in normal tissues assessed by PET during treatment has prognostic value for treatment results in head and neck squamous cell carcinomas undergoing radiochemotherapy

Zschaeck, S., Löck, S., Leger, S., Haase, R., Bandurska‐Luque, A., Appold, S., Kotzerke, J., Zips, D., Richter, C., Gudziol, V., et al. (2017) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2017.01.019 · Cited by 10 · see citing works

Impact of granulocyte colony–stimulating factors in metastatic colorectal cancer patients

Amadio, A. V., Burkes, R. L., Bailie, T., McLean, M., & Coleman, B. L. (2013) · Current Oncology · doi:10.3747/co.21.1645 · Cited by 10 · see citing works

Timing of Severe Toxicity from Chemotherapy in Patients With Lung Cancer

SJØGREN, K., Jacobsen, K. A., Grønberg, B. H., & Halvorsen, T. O. (2020) · Anticancer Research · doi:10.21873/anticanres.14661 · Cited by 10 · see citing works

Retrospective Analysis of Severe Neutropenia in Patients Receiving Concomitant Administration of Docetaxel and Clarithromycin

Tsuji, D., Kamezato, M., Daimon, T., Taku, K., Hatori, M., Ikeda, M., Hayashi, H., Inoue, K., Eto, T., & Itoh, K. (2013) · Chemotherapy · doi:10.1159/000362437 · Cited by 10 · see citing works

Chemotherapy Induced Neutropenia, Febrile-Neutropenia and Determinants Among Solid Cancer Patients Attending Oncology Unit of a Tertiary Care Teaching Hospital in Ethiopia

Dessalegn, M., Fantahun, M., Yesufe, A. A., Hussein, M., & Tsegaye, A. (2023) · Cancer Management and Research · doi:10.2147/cmar.s386181 · Cited by 9 · see citing works

Comparative analysis of carboplatin and paclitaxel combination chemotherapy schedules in previously untreated patients with advanced non-small cell lung cancer

Shimizu, T., Yokoi, T., Tamaki, T., Kibata, K., Inagaki, N., & Nomura, S. (2013) · Oncology Letters · doi:10.3892/ol.2013.1134 · Cited by 9 · see citing works

Score of the preoperative absolute number of lymphocytes, monocytes, and neutrophils as a prognostic indicator for patients with gastric cancer

Saito, H., Shimizu, S., Kono, Y., Murakami, Y., Shishido, Y., Miyatani, K., Matsunaga, T., Fukumoto, Y., Ashida, K., & Fujiwara, Y. (2019) · Surgery Today · doi:10.1007/s00595-019-01817-6 · Cited by 8 · see citing works

Association of Chemotherapy-induced Leucopenia with Treatment Outcomes in Advanced Non-small-cell lung Cancer Cases Receiving the NP Regimen

Huang, C., Liu, L., Liu, J., Chen, Z., Guo, J., Li, C., Zhou, D.-G., & Wang, Z. (2012) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2012.13.9.4481 · Cited by 7 · see citing works

Prognosticating Survival in Hepatocellular Carcinoma with Elevated Baseline Alpha-fetoprotein Treated with Radioembolization Using a Novel Laboratory Scoring System: Initial Development and Validation

Ali, R., Yang, Y., Antkowiak, M., Gabr, A., Mora, R. A., Abouchaleh, N., Asadi, A. A., Kulik, L., Ganger, D. R., Abecassis, M. M., et al. (2019) · CardioVascular and Interventional Radiology · doi:10.1007/s00270-019-02191-z · Cited by 7 · see citing works

Chemotherapy-induced neutropenia as a prognostic factor in patients with extensive-stage small cell lung cancer

Miyagi, T., Tsuji, D., Kawasakai, Y., Ishikawa, H., Tanaka, R., Nakao, M., Nakagaki, S., Hayashi, T., Ayuhara, H., Harada, T., et al. (2023) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-023-03451-1 · Cited by 7 · see citing works

Randomized Phase II Study Comparing Dose Escalated Weekly Paclitaxel vs. Standard Dose Weekly Paclitaxel for Patients with Previously Treated Advanced Gastric Cancer

Shitara, K., Oze, I., Mizota, A., Kondo, C., Nomura, M., Yokota, T., Takahari, D., Ura, T., Yuki, S., Komatsu, Y., et al. (2010) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyq206 · Cited by 7 · see citing works

Dose considerations for anti-cancer drugs in metastatic prostate cancer

Crumbaker, M., & Gurney, H. (2017) · The Prostate · doi:10.1002/pros.23378 · Cited by 6 · see citing works

Predictive value of inflammatory indexes on the chemotherapeutic response in patients with unresectable lung cancer: A retrospective study

Sun, H., Hu, P., Du, J., & Wang, X. (2018) · Oncology Letters · doi:10.3892/ol.2018.7781 · Cited by 6 · see citing works

Reduction of derived neutrophil-to-lymphocyte ratio after four weeks predicts the outcome of patients receiving second-line chemotherapy for metastatic colorectal cancer

Colloca, G. A., Venturino, A., & Guarneri, D. (2020) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-020-02761-y · Cited by 6 · see citing works

Randomized Phase II Study of Weekly Paclitaxel plus Carboplatin Versus Biweekly Paclitaxel plus Carboplatin for Patients with Previously Untreated Advanced Non-Small Cell Lung Cancer

Takayama, K., Ichiki, M., Tokunaga, S., Inoue, K., Kawasaki, M., Uchino, J., & Nakanishi, Y. (2019) · The Oncologist · doi:10.1634/theoncologist.2019-0513 · Cited by 5 · see citing works

Whole genome gene expression changes and hematological effects of rikkunshito in patients with advanced non-small cell lung cancer receiving first line chemotherapy

Chen, Y., Lin, A.-S., Hung, Y., Chen, K., Wu, C., Lie, C.-H., Hsiao, C., Chen, C., Liu, S., Fang, W., et al. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.4773 · Cited by 4 · see citing works

Preoperatif Nötrofil/Lenfosit, Lenfosit/Monosit ve Trombosit/Lenfosit Oranlarının Seröz Over Kanseri Sağ Kalımındaki Yeri

ERBEN, S. D., Kılıç, F., Ünsal, M., Aytekın, O., Cömert, G. K., Karalök, A., Türkmen, O., Tapısız, Ö. L., Turan, T., & Tulunay, G. (2021) · Balıkesir Medical Journal · doi:10.33716/bmedj.871929 · Cited by 3 · see citing works

Absolute Neutrophil Count after the First Chemotherapy Cycle as a Surrogate Marker for Treatment Outcomes in Patients with Neuroblastoma

Lee, J. W., Bae, J. S., Kim, J. H., Cho, H. W., Ju, H. Y., Yoo, K. H., Koo, H. H., Woo, S., Kim, S., & Sung, K. W. (2021) · Cancer Research and Treatment · doi:10.4143/crt.2021.010 · Cited by 3 · see citing works

Effects of Chemotherapy-Induced Neutropenia on Overall Survival in Patients With Unresectable or Metastatic Urothelial Carcinoma to Gemcitabine Plus Cisplatin Combination Chemotherapy

Yamamoto, K., Sasano, T., Tsuji, D., Ishizuka, Y., Tokou, U., Nakamichi, H., Yoneda, T., Shiokawa, M., & Yabe, K. (2019) · Annals of Pharmacotherapy · doi:10.1177/1060028019830785 · Cited by 3 · see citing works

Emergency surgery for patients with cancer receiving systemic anticancer therapy

Coulson, K., Day, N., Strach, M. C., & Sutton, P. A. (2023) · British journal of surgery · doi:10.1093/bjs/znad007 · Cited by 2 · see citing works

Identification of small cell lung cancer patients who are at risk of developing common serious adverse event groups with machine learning

Wanika, L., Evans, N. D., & Chappell, M. J. (2023) · Frontiers in Drug Safety and Regulation · doi:10.3389/fdsfr.2023.1267623 · Cited by 1 · see citing works

Relationship between neutropenia caused by nanoliposomal irinotecan/fluorouracil/leucovorin and treatment outcomes in the NAPOLEON-2 study (NN-2301)

Araki, T., Sonoda, Y., Shimokawa, M., Otsuka, T., Hayashi, K., Honda, T., Nakao, K., Shibuki, T., Nakazawa, J., Arima, S., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-88005-4 · Cited by 1 · see citing works

Chemotherapy‐induced neutropenia predicts short‐term outcome of patients with pancreatic cancer treated with nanoliposomal irinotecan, fluorouracil, and folinic acid

Araki, T., Shirakawa, T., Shimokawa, M., Otsuka, T., Hayashi, K., Sonoda, Y., Honda, T., Miyaaki, H., Nakazawa, J., Shimokawa, H., et al. (2025) · International Journal of Cancer · doi:10.1002/ijc.70072 · Cited by 1 · see citing works

Estudio retrospectivo de la influencia de la respuesta al tratamiento quimioterápico de primera línea en pacientes con cáncer no microcítico de pulmón sobre la respuesta a la administración de factores estimulantes de la eritropoyesis en la anemia inducida por quimioterapia

Mollá, S. B., Molins, A. B., & Blesa, J. M. G. (2012)

Timing of chemotherapy-induced neutropenia is a prognostic factor in patients with diffuse large B-cell lymphoma: a retrospective studyPreprint

Qiu, J., Zhang, B., Bu, B., Fang, S., & Song, L. (2021) · Research Square · doi:10.21203/rs.3.rs-285196/v1

Tumour size, new lesions and other markers as longitudinal endpoints in oncology studies

Lombard, A. (2021) · Research Explorer (The University of Manchester)

Current World Literature

(2011) · Current Opinion in Oncology · doi:10.1097/cco.0b013e328344b687

Association between Severe Neutropenia Induced by Amrubicin Therapy and Progression-free Survival in Recurrent Small Cell Lung Cancer

Ishida, S., Seo, K., Miyazaki, J., Nakai, M., Mizukami, K., Shiraki, M., Sakata, Y., & Watanabe, A. (2023) · Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences) · doi:10.5649/jjphcs.49.374

A phase I/II trial evaluating the safety of increased-dose S- 1 with oxaliplatin and nivolumab in HER2-negative advanced gastric cancer

Baba, K., Suzuki, N., Imamura, C. K., Booka, E., Takeuchi, M., Takahari, D., Kawakami, T., Kawakubo, H., Kitagawa, C., Kono, Y., et al. (2025) · BMC Cancer · doi:10.1186/s12885-025-14084-1

A Phase II Study of Bendamustine Plus Rituximab in Patients with Relapsed or Progressive Marginal Zone Lymphoma: KCSG LY14-09

Lee, J.-O., Park, J., Kang, H. J., Hyun, S. Y., Lee, G., Yhim, H., Kim, H. J., Lee, J. S., Heo, D. S., & Kim, T. M. (2025) · Cancer Research and Treatment · doi:10.4143/crt.2025.815

Additional file 1 of Prognostic potential of pre-partum blood biochemical and immune variables for postpartum mastitis risk in dairy cows

Guan, R.-W., Wang, D., Wang, B.-B., Jiang, L.-Y., & Liu, J. (2020) · Figshare · doi:10.6084/m9.figshare.12308186

Additional file 1 of Chemotherapy-induced neutropenia and treatment efficacy in advanced non-small-cell lung cancer: a pooled analysis of 6 randomized trials

Gargiulo, P., Arenare, L., Gridelli, C., Morabito, A., Ciardiello, F., Gebbia, V., Maione, P., Spagnuolo, A., Palumbo, G., Esposito, G., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14594177

Therapy-Induced Neutropenia and Poor Prognosis in Patients with Locally Advanced Esophageal Cancer Who Underwent Concurrent Chemoradiotherapy with Docetaxel, Cisplatin, and 5-Fluorouracil

Sakai, M., Nakazawa, N., Kuriyama, K., Okada, T., Shiraishi, T., Kumakura, Y., Kimura, A., Sano, A., Yokobori, T., Shirabe, K., et al. (2025) · Cancers · doi:10.3390/cancers18010112

[18F]AlF-NOTA-QHY-04 uptake in spleen before anti-tumor therapy may predict degree of myelosuppression for patients with small cell lung cancer

Cai, S., Liu, J., Cheng, K., Zhao, X., Xu, S., Pei, J., Wang, S., Zhao, K., Yu, J., Li, W., et al. (2026) · Cancer Imaging · doi:10.1186/s40644-026-01024-w

Early-onset hematological toxicity of docetaxel and survival in non-small cell lung cancer patients in the immune checkpoint inhibition era

Kicken, M. P., Grotenhuis, A. J., de Kok, S., van den Borne, B. E. E. M., Rouw, N., van der Leest, K. H., Peters, B. J. M., Brinkman, I., van Putten, J. W. G., Franssen, E. J. F., et al. (2026) · Cancer Treatment and Research Communications · doi:10.1016/j.ctarc.2026.101259

Re-evaluating the Neutropenia–Survival Paradigm in Irinotecan-based Therapy for Advanced Gastric Cancer: Post-Hoc Analysis of the RINDBeRG TrialPreprint

Sakakida, T., Narita, Y., Mizuno, T., Ishizuka, Y., Kadowaki, S., Muro, K., Tamura, S., Yamaguchi, H., Shimokawa, T., Sakai, D., et al. (2026) · Research Square · doi:10.21203/rs.3.rs-9835081/v1

Development of a simplified population pharmacokinetic–pharmacodynamic framework for exposure-informed risk stratification of neutropenia during amrubicin treatment

Makino, Y., Ogawa, T., Ando, R. M., Sakiyama, N., Yamazaki, M., Naito, C., Takayama, H., Ueda, G., Kohyama, S., Todo, M., et al. (2026) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-026-04931-8

Re-evaluating the neutropenia–survival paradigm in irinotecan-based therapy for advanced gastric cancer: post-hoc analysis of the RINDBeRG trial

Sakakida, T., Narita, Y., Mizuno, T., Ishizuka, Y., Kadowaki, S., Muro, K., Tamura, S., Yamaguchi, H., Shimokawa, T., Sakai, D., et al. (2026) · International Journal of Clinical Oncology · doi:10.1007/s10147-026-03221-w

Chemotherapy-induced neutropenia and treatment efficacy in advanced non-small-cell lung cancer: a pooled analysis of 6 randomized trials

Gargiulo, P., Arenare, L., Gridelli, C., Morabito, A., Ciardiello, F., Gebbia, V., Maione, P., Spagnuolo, A., Palumbo, G., Esposito, G., et al. (2021) · BMC Cancer · doi:10.1186/s12885-021-08323-4 · Cited by 22 · see citing works

Chemotherapy-Induced Neutropenia as a Predictor of Survival in Patients with Advanced Non-Small Cell Lung Cancer

Yeh, C.-S., Chen, C.-H., Ji, B., & Lin, C. (2010) · 胸腔醫學 · doi:10.29806/tm.201006.0001

Early-onset neutropenia during perioperative chemotherapy is predictive of increased survival in patients with completely resected non-small cell lung cancer: a retrospective analysis.

Lee, C. Y., Park, S. Y., Shin, T. R., Park, Y. B., Kim, C.-H., Jang, S. H., & Lee, J. W. (2013) · PubMed · Cited by 8 · see citing works

Chemotherapy-induced neutropenia and treatment efficacy in advanced non-small-cell lung cancer: a pooled analysis of three randomised trials

Maïo, M. D., Gridelli, C., Gallo, C., Shepherd, F. A., Piantedosi, F. V., Cigolari, S., Manzione, L., Illiano, A., Barbera, S., Robbiati, S. F., et al. (2005) · The Lancet Oncology · doi:10.1016/s1470-2045(05)70255-2 · Cited by 235 · see citing works

Irinotecan and cisplatin therapy-induced neutropenia as a prognostic factor in patients with extensive-disease small cell lung cancer

Ishikawa, H., Tsuji, D., Miyagi, T., Kawasaki, Y., Yamamoto, K., Nakao, M., Nakagaki, S., Hayashi, T., Ayuhara, H., Harada, T., et al. (2019) · Annals of Oncology · doi:10.1093/annonc/mdz420.008 · Cited by 1 · see citing works